Porphyromonas gingivalis Outer Membrane Vesicles as the major driver of and explanation for the Neuropathogenesis, The Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer’s Disease

Manuscript Number: 


W. Sue T. Griffin, Peter Nara, Marc Penn, Jan Potempa, Daniel Sindelar


Susan Griffin

  • Nothing to Disclose

Peter Nara

  • Equity:
    common shares in Biological Mimetics, Inc., Lantern Pharma Inc. and Keystone Bio Inc.
    I am the CSO for Keystone Bio Inc. This was a a hypothesis paper so it was not formerly paid for but for my writing time.
    I have many patents related to my life long career in biomedical science and co-founding 3 biotechnology companies. There is one major provisional patent filed related to Keystone Bio which is working in this area.

Marc Penn

  • Consulting Fees:
    Consulting Chief Medical Officer - Keystone Bio, Inc.
    Options as Chief Medical Officer - Keystone Bio, Inc.
    Chief Medical Officer

Jan Potempa

  • Consulting Fees:
    Cortexyme, Inc. - Scientific Advisory Board PerioTrap Pharmaceuticals - Advisory Board
    Cortexyme, Inc.

Daniel Sindelar

  • Equity:
    I own stock and options in Keystone Bio, Inc
    I am the CEO.

W. Sue T. Griffin

  • Disclosure not yet completed